IMPACT: Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)

• Sponsor: Centre Hospitalier Universitaire Dijon (Other)
• Overall Status: Completed
• CT.gov ID: NCT02855879
• Collaborator: (none)
• Enrollment: 286
• Location: 1
• Actual Duration (Months): 49.9
• Patients Per Site Per Month: 5.7

Study Details

Study Description

Brief Summary

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG).

In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Condition or Disease	Intervention/Treatment	Phase
Anomalies in Glucose Metabolism; Coronary Artery Bypass Graft	Other: Collection of biological data; Other: Collection of clinical data

Study Design

• Study Type: Observational
• Actual Enrollment: 286 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft, Consequences for Morbi/Mortality in the Short and Medium Term
• Actual Study Start Date: Apr 8, 2015
• Actual Primary Completion Date: Jun 5, 2019
• Actual Study Completion Date: Jun 5, 2019

Arms and Interventions

Arm	Intervention/Treatment
CAD patients	Other: Collection of biological data; Other: Collection of clinical data

Outcome Measures

Primary Outcome Measures

1. Percentage of glucose anomalies (non-diabetic fasting hyperglycaemia, glucose intolerance, diabetes) in CAD patients about to undergo coronary artery bypass grafting. [Change from inclusion to week 2 and up to month 3]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• persons who have provided oral consent

• patients about to undergo coronary artery bypass grafting

• age >18 years

Exclusion Criteria:

• persons without national health insurance cover

• Adults under guardianship

• Pregnant or breast-feeding women

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU Dijon Bourgogne	Dijon		France	21079

Sponsors and Collaborators

• Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Centre Hospitalier Universitaire Dijon
• ClinicalTrials.gov Identifier: NCT02855879
• Other Study ID Numbers: VERGES 2014
• First Posted: Aug 4, 2016
• Last Update Posted: Dec 11, 2019
• Last Verified: Dec 1, 2019

• Additional relevant MeSH terms: Congenital Abnormalities

Study Results

No Results Posted as of Dec 11, 2019